Skip to main content
Premium Trial:

Request an Annual Quote

Bruce Alberts on Innovation

As a reviewer for the NIH Director's New Innovator Award in 2007, Science editor-in-chief Bruce Alberts says that his pile of applications contained "bold, original ideas" and that "at least 4 of my 35 should have been funded." None were, he adds. Alberts says that this grant award and similar ones focused on innovation "make a big difference to those who receive them. But there are far too few to change the culture for scientists starting new labs," he writes. "Most remain unwilling to take the risk of pursuing ambitious ideas, recognizing that extensive preliminary results will be required to obtain funding from a traditional study section." At Adaptive Complexity, Michael White adds: "We need to overhaul the way bread-and-butter R01's get evaluated, so that near-certain feasibility is not the top criterion for funding."

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.